老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Plus Therapeutics, Inc.

0.5052
+0.02014.14%
盘后：0.51200.0068+1.35%17:29 EDT
成交量：844.11万
成交额：436.20万
市值：5,014.84万
市盈率：-0.22
高：0.5390
开：0.5155
低：0.4875
收：0.4851
52周最高：2.31
52周最低：0.1634
股本：9,926.45万
流通股本：6,039.28万
量比：1.64
换手率：13.98%
股息：- -
股息率：- -
每股收益(TTM):-2.3407
每股收益(LYR):-1.9544
净资产收益率：-522.50%
总资产收益率：-74.05%
市净率：16.53
市盈率(LYR):-0.26

数据加载中...

总览公司新闻公告
2021/01/12

重要事件披露

8-K - Current report
2020/11/03

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/10/23

重要事件披露

8-K - Current report
2020/10/22

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/22

重要事件披露

8-K - Current report
2020/10/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/06

重要事件披露

8-K - Current report
2020/10/05

重要事件披露

8-K - Current report
2020/09/15

重要事件披露

8-K - Current report
2020/08/10

重要事件披露

8-K - Current report
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report
2020/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/17

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report
2020/05/26

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/14

重要事件披露

8-K - Current report
2020/05/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
更多